2862 The influence of time to objective response on lenvatinib clinical outcomes in the phase 3 SELECT trial. (September 2015) - Newbold, K.; Sherman, S.; Wirth, L.J.; Habra, M.A.; Rietschel, P.; Song, J.; Schlumberger, M.; Gianoukakis, A.